Pharmacogenomics and Personalized Medicinehttps://www.dovepress.com/feed/journal/38New articles released by Dove Press for Pharmacogenomics and Personalized Medicineen-us2026, Dove Pressangela@dovepress.com (Angela Jones)Dove Press Pharmacogenomics and Personalized MedicinePharmacogenomics and Personalized Medicinehttps://www.dovepress.com/feed/journal/38https://www.dovepress.com/assets/img/addon/rss-banner.jpg140140Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Reporthttps://www.dovepress.com/massive-hepatocellular-carcinoma-with-insufficient-future-liver-remnan-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineTue, 07 Apr 2026 20:20:00 +1200https://doi.org/10.2147/PGPM.S578577Construction and Validation of Multi-Omics Predictive Models for Colorectal Cancer Using Machine-Learning Approacheshttps://www.dovepress.com/construction-and-validation-of-multi-omics-predictive-models-for-color-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineThu, 02 Apr 2026 05:45:00 +1300https://doi.org/10.2147/PGPM.S566928NAT2 Acetylation Phenotypes in India: A Narrative Review of Personalized TB Therapyhttps://www.dovepress.com/nat2-acetylation-phenotypes-in-india-a-narrative-review-of-personalize-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineTue, 10 Mar 2026 03:45:00 +1300https://doi.org/10.2147/PGPM.S568037Bioinformatic Identification and Preliminary Validation of TP53, TGFB1, and NFE2L2 as Potential Ferroptosis-Related Regulators in Pancreatic Adenocarcinomahttps://www.dovepress.com/bioinformatic-identification-and-preliminary-validation-of-tp53-tgfb1--peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineTue, 17 Feb 2026 00:15:00 +1300https://doi.org/10.2147/PGPM.S562602Clinical Outcomes of Osimertinib Combined with Platinum-Based Chemotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Studyhttps://www.dovepress.com/clinical-outcomes-of-osimertinib-combined-with-platinum-based-chemothe-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineTue, 03 Feb 2026 00:00:00 +1300https://doi.org/10.2147/PGPM.S566952Post-Translational Modifications of Histones and Non-Histones in Liver Disease and Traditional Chinese Medicine Treatment: A Narrative Reviewhttps://www.dovepress.com/post-translational-modifications-of-histones-and-non-histones-in-liver-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineTue, 03 Feb 2026 00:00:00 +1300https://doi.org/10.2147/PGPM.S555701Managing Refractory Hypertension: A Case Study Exploring the Influence of ACE and ACTN3 Gene Polymorphismshttps://www.dovepress.com/managing-refractory-hypertension-a-case-study-exploring-the-influence--peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineFri, 19 Dec 2025 06:20:00 +1300https://doi.org/10.2147/PGPM.S528939Case Report: Successful Surgical Resection of PVTT Vp4 Hepatocellular Carcinoma Following Hepatic Arterial Infusion Chemotherapy Combined with Cadonilimab Plus Donafenibhttps://www.dovepress.com/case-report-successful-surgical-resection-of-pvtt-vp4-hepatocellular-c-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineSat, 06 Dec 2025 19:15:00 +1300https://doi.org/10.2147/PGPM.S555061Berberine Repairs Intestinal Mucosal Barrier by Targeting HSP90AA1 and MAPK14https://www.dovepress.com/berberine-repairs-intestinal-mucosal-barrier-by-targeting-hsp90aa1-and-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineSat, 15 Nov 2025 01:25:00 +1300https://doi.org/10.2147/PGPM.S547308Genetic Landscape of VIP Pharmacogenomic Variants in the Kinh Vietnamese Populationhttps://www.dovepress.com/genetic-landscape-of-vip-pharmacogenomic-variants-in-the-kinh-vietname-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineTue, 14 Oct 2025 23:20:00 +1300https://doi.org/10.2147/PGPM.S520685Whole Exome Sequencing Reveals Novel Genetic Variants Associated with Atrial Septal Defect in a Tibetan Patient Cohorthttps://www.dovepress.com/whole-exome-sequencing-reveals-novel-genetic-variants-associated-with--peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineWed, 10 Sep 2025 22:05:00 +1200https://doi.org/10.2147/PGPM.S525556Ulcerative Colitis: Advances in Pathogenesis, Biomarkers, and Therapeutic Strategieshttps://www.dovepress.com/ulcerative-colitis-advances-in-pathogenesis-biomarkers-and-therapeutic-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineFri, 05 Sep 2025 17:05:00 +1200https://doi.org/10.2147/PGPM.S536459Association Between ABCB1 Gene Polymorphism with Hyperglycemia and MACE in Patients Undergoing Clopidogrel Treatment After PCIhttps://www.dovepress.com/association-between-abcb1-gene-polymorphism-with-hyperglycemia-and-mac-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineMon, 25 Aug 2025 19:05:00 +1200https://doi.org/10.2147/PGPM.S529276The Prevalence of Potential Drug-Drug-Gene Interactions: A Descriptive Study Using Swiss Claims Datahttps://www.dovepress.com/the-prevalence-of-potential-drug-drug-gene-interactions-a-descriptive--peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineSat, 23 Aug 2025 23:25:00 +1200https://doi.org/10.2147/PGPM.S527556Dual EGFR L858R and KRAS G12A Mutations in Lung Adenocarcinoma: A Rare Case Report and Literature Reviewhttps://www.dovepress.com/dual-egfr-l858r-and-kras-g12a-mutations-in-lung-adenocarcinoma-a-rare--peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineFri, 22 Aug 2025 00:45:00 +1200https://doi.org/10.2147/PGPM.S531038Construction of a Nomogram Model for Predicting Prognosis in Breast Cancer Patients Based on the Expression of THRSP and ACACA Proteins Tissueshttps://www.dovepress.com/construction-of-a-nomogram-model-for-predicting-prognosis-in-breast-ca-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineThu, 31 Jul 2025 18:05:00 +1200https://doi.org/10.2147/PGPM.S516843Advances in the Clinical Use of Clopidogrel: A Review of Individualized Treatment Strategies and Monitoring Optimization Based on Genetic Polymorphismshttps://www.dovepress.com/advances-in-the-clinical-use-of-clopidogrel-a-review-of-individualized-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineWed, 09 Jul 2025 21:25:00 +1200https://doi.org/10.2147/PGPM.S519342Molecular Genetic Analysis of a DMD Frameshift Mutation in a Boy with Duchenne Muscular Dystrophy by MLPA and Sanger Sequencinghttps://www.dovepress.com/molecular-genetic-analysis-of-a-dmd-frameshift-mutation-in-a-boy-with--peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineTue, 17 Jun 2025 22:55:00 +1200https://doi.org/10.2147/PGPM.S514145Associations Between FTO Polymorphisms and Neuroblastoma Risk in Chinese Childrenhttps://www.dovepress.com/associations-between-fto-polymorphisms-and-neuroblastoma-risk-in-chine-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineTue, 27 May 2025 02:30:00 +1200https://doi.org/10.2147/PGPM.S488314Quercetin Inhibits Gastric Cancer Progression via FAM198B/MAPK Pathway Modulationhttps://www.dovepress.com/quercetin-inhibits-gastric-cancer-progression-via-fam198bmapk-pathway--peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineThu, 15 May 2025 21:40:00 +1200https://doi.org/10.2147/PGPM.S511324Prevalence of CYP2C19 Variants in Patients with Cardiovascular Disease from the Yunnan-Guizhou Plateau in Southwestern Chinahttps://www.dovepress.com/prevalence-of-cyp2c19-variants-in-patients-with-cardiovascular-disease-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineFri, 02 May 2025 01:15:00 +1200https://doi.org/10.2147/PGPM.S509794Clinicopathological and Molecular Features of Primary Inflammatory Myofibroblastic Tumor in Nasal Cavity and Paranasal Sinuseshttps://www.dovepress.com/clinicopathological-and-molecular-features-of-primary-inflammatory-myo-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineMon, 28 Apr 2025 19:00:00 +1200https://doi.org/10.2147/PGPM.S508156Novel SLC16A2 Frameshift Mutation as a Cause of Allan-Herndon-Dudley Syndrome and its Implications for Carrier Screeninghttps://www.dovepress.com/novel-slc16a2-frameshift-mutation-as-a-cause-of-allan-herndon-dudley-s-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineWed, 23 Apr 2025 00:05:00 +1200https://doi.org/10.2147/PGPM.S492647Pharmacogenomics of Chemotherapies for Childhood Cancers in Africa: A Scoping Reviewhttps://www.dovepress.com/pharmacogenomics-of-chemotherapies-for-childhood-cancers-in-africa-a-s-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineFri, 14 Feb 2025 03:05:00 +1300https://doi.org/10.2147/PGPM.S502355Association of MiRNA Polymorphisms Involved in the PI3K/ATK/GSK3β Pathway with T2DM in a Chinese Populationhttps://www.dovepress.com/association-of-mirna-polymorphisms-involved-in-the-pi3katkgsk3-pathway-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineFri, 14 Feb 2025 02:45:00 +1300https://doi.org/10.2147/PGPM.S487873A Novel Pathogenic Splicing Mutation of OFD1 is Responsible for a Boy with Joubert Syndrome Exhibiting Orofaciodigital Spectrum Anomalies, Polydactyly and Retinitis Pigmentosahttps://www.dovepress.com/a-novel-pathogenic-splicing-mutation-of-ofd1-is-responsible-for-a-boy--peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineMon, 03 Feb 2025 15:25:00 +1300https://doi.org/10.2147/PGPM.S501623Naoxintong Is Involved in the Coagulation Regulation of Warfarin Through the MAPK Pathwayhttps://www.dovepress.com/naoxintong-is-involved-in-the-coagulation-regulation-of-warfarin-throu-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineFri, 31 Jan 2025 18:55:00 +1300https://doi.org/10.2147/PGPM.S489820Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Reviewhttps://www.dovepress.com/pharmacogenomics-tools-for-precision-public-health-and-lessons-for-low-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineThu, 30 Jan 2025 02:55:00 +1300https://doi.org/10.2147/PGPM.S490135Identification of Bacterial Lipopolysaccharide-Associated Genes and Molecular Subtypes in Autism Spectrum Disorderhttps://www.dovepress.com/identification-of-bacterial-lipopolysaccharide-associated-genes-and-mo-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineFri, 17 Jan 2025 18:55:00 +1300https://doi.org/10.2147/PGPM.S494126PEAR1, PON1, CYP2C19, CYP1A2 and F2R Polymorphisms are Associated with MACE in Clopidogrel-Treated Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Interventionhttps://www.dovepress.com/pear1-pon1-cyp2c19-cyp1a2-and-f2r-polymorphisms-are-associated-with-ma-peer-reviewed-fulltext-article-PGPMPharmacogenomics and Personalized MedicineSat, 21 Dec 2024 22:20:00 +1300https://doi.org/10.2147/PGPM.S490030